Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vivi2g06020 | ATGTCAAGCTTCAAACATGTATCCATGTTCTTCTTTTTGTTTCTGGCTTTCAATTGTTTCTCTTTGCTTGGATCCAACGCTAAAGTCCTACCACAAGATGAAGTGAAATTGCTCCAAACAATATCAGACAAGTTAGAAAACTTAAATTGGAAGGTTACACAAGGTTCTTGCAATGATGATAATGGATTTGGTAACAAGAATATTTCAAAGGATATTTTAAGCAGTGTCACATGTGATTGTACTTTCAACTCTAGCACTGTCTGCCATGTCACAAACATCTTGCTCAAGGGTCTGAATATATCTGGAGTTATTCCAAATGAATTTGGAAATCTCACTCAACTCAAAGTACTTGATCTCTCTAGGAATTACTTAAATGGTTCAATTCCAAAGAGTCTTGGAGTCCTCTCACTTGTGACATTGGCATTTTTGGGAAATCAGCTTAGTGGTCCAATTCCCTCAGAACTTGGTAACATTGCAACACTACAAGAACTGACCTTAGAGGATAATCTACTTGAAGGACCTCTTCCTTCTAGCCTTGGAAATTTGAAACACTTGGAGGATTTAAAGCTTTCTGCAAATAATTTTACAGGGAGGATACCAGAATCATATGGAAATCTGAAGAATCTCACTGATTTTAGGCTAGACGGAAGCAGTTTATCTGGGAAAATTCCGAGTTTTATTGGAAACTGGACGAAACTTGAAAGATTGGATTTGCAAGGCACGTCGATGGAAGGTCCAATTCCTCCTGCTATATCTCTCTTGAAAAGTTTGAAGGAATTGAGAATATCTGATTTGAAGGGGAACACAACCATGGCATTTCCTGATCTGAAAAATTTGACACGCATGACGAAACTGGAATTGAGAAATTGCTTAATCAGTGGTCCTATTTTAGACTCCATTGGTGAATTGGAAAATTTAAAAACTCTAGATTTGAGCTCCAATAGATTGACCGGTCCAATTCCAGATTCATTTGAGAACTTGGAAGCTATCAATTTCATGTTTCTGACCAACAACTCTCTAAATGGAACAACTCCCGGATGGATATTGACCAACAAACATAACTTTGATTTATCTTTCAACAATTTTTCCGAGTCTTCTGCAACTACTTGCCAGCCCTTGGACGTGAACTTAGCCTCGAGCGTCTCTTCTTCAGCAAACACTTCACTGTCTTGTTTGAAGGCGAACCTACCTTGTTCGGGAAAATCTCAGTATCACTCATTGTATATAAATTGTGGAGGACCCGCAATAGAGGTTGATGACAAAGAATATGAAGCCGACGAACATTTACGTGGAATTTCGAACTTTGTTGAAAGTCCTGATGGAAAATGGGCTTATAGCAGCACAGGAGTATTTCTAGGAAATGAAAAAGCTGATTATGTGGCAACAAATGTTTTCTCTTTGGATATTAATGGCTCTGGATACTACCAAACAGCCCGCATTGCGCCGATATCTCTTAACTACTTTGGATTTTGTATGATGAAGGGAAACTATAATGTGAAACTTCATTTTGCTGAGATAATGTTTTCTAATGACCGGACATTTAGCAGCCTTGGAAGGCGCATATTCGATGTTTCAATTCAAGGTCATAAATATTTAAAAGACTTTAACATTATGGAAGAAGCCGGCGGAGTTGGCAAGGGAATTACTAAGGACTTTAATGTTGATGTTAATGAAAGCACCTTGCAAATCCACTTATCTTGGGCAGGAAAAGGAACTAATGCAATTCCTATGCGAGGTGTATATGGACCACTTATATCTGCTATCACCGTGACCCCAAACTTTAAAATTCCTTCGAATGGTTTGTCTGCTGGAGCAATTGCTGGAATTGTGATTGGATCATTGGCATTTGTTTTGCTGATACTCTTTGTCCTTTGGAAGATGGGTTACATTTTTCGGAAAGATCAAACAGACAAAGAACTCCTAGAATTGAAAACGGGCTATTTCAGTTTGAGACAAATTAAAGCTGCTACTAATAACTTTGATCTAGTAAATAAGATAGGTGAAGGAGGATTTGGGCCTGTTTACAAGGGTATACTGTCAGATGGTGCTGTGATTGCGGTTAAACAGCTCTCGTCGAAATCAAAGCAAGGGAACCGTGAATTCGTAAACGAAATAGGCATGATATCTGCTTTGCAGCATCCCAATCTTGTGAAACTTTATGGATGTTGCATTGAAGGAAACCAATTGCTGCTTGTATATGAATACATGGAGAACAATAGTCTTGCTCGCGCTATTTTCGGTAAGCCAGAACAAAAGTTGAACTTGGACTGGCGCACGAGGATGAAGATTTGTGTAGGGATAGCAAGAGGGTTAGCCTATCTTCATGAGGAATCAAGGCTGAAAATAGTACACAGAGATATTAAGGCAACTAATGTCTTACTCGATAAGCATCTGAATGCCAAGATCTCTGATTTCGGTTTAGCCAAGCTTGATGAAGAAGAAAACACTCATATCAGCACGCGAATAGCTGGGACAATAGGCTACATGGCTCCTGAGTATGCTATGCGGGGTTACTTGACCGACAAAGCAGATGTATATAGTTTTGGAGTTGTAGCCTTAGAGATTGTAAGTGGAATGAGCAACACGAATTATAGGCCAAAAGAGGAATTTGTTTATCTTCTGGATTGGGCTTATGTTCTCCAAGAACAAGGAAACCTTCTGGAATTGGTGGATCCAAGTCTCGGTTCAAAGTACTCATCAGAGGAGGCCATGAGAATGCTGCAATTGGCACTCCTTTGCACCAATCCATCTCCAACTCTTAGACCACCAATGTCATCTGTAGTAAGCATGCTTGAAGGAAACACTCCAATTCAAGCGCCGATCATCAAGCGAAGCGATAGTACAAGTGGTGCAAGATTTAAAGCCTTTGAGCTTCTATCACATGATAGCCAAACTAATGTTTCTTCAACATCCTTACAAGATAGTAGAGAGCTAAGAGGCAAATCAATGGATGGACCATGGGTTGATTCTTCCATATCTTATCCAAGTAAAGATTATTCTTCATCTGATAGGCTTATTTGA | 3021 | 0.3932 | MSSFKHVSMFFFLFLAFNCFSLLGSNAKVLPQDEVKLLQTISDKLENLNWKVTQGSCNDDNGFGNKNISKDILSSVTCDCTFNSSTVCHVTNILLKGLNISGVIPNEFGNLTQLKVLDLSRNYLNGSIPKSLGVLSLVTLAFLGNQLSGPIPSELGNIATLQELTLEDNLLEGPLPSSLGNLKHLEDLKLSANNFTGRIPESYGNLKNLTDFRLDGSSLSGKIPSFIGNWTKLERLDLQGTSMEGPIPPAISLLKSLKELRISDLKGNTTMAFPDLKNLTRMTKLELRNCLISGPILDSIGELENLKTLDLSSNRLTGPIPDSFENLEAINFMFLTNNSLNGTTPGWILTNKHNFDLSFNNFSESSATTCQPLDVNLASSVSSSANTSLSCLKANLPCSGKSQYHSLYINCGGPAIEVDDKEYEADEHLRGISNFVESPDGKWAYSSTGVFLGNEKADYVATNVFSLDINGSGYYQTARIAPISLNYFGFCMMKGNYNVKLHFAEIMFSNDRTFSSLGRRIFDVSIQGHKYLKDFNIMEEAGGVGKGITKDFNVDVNESTLQIHLSWAGKGTNAIPMRGVYGPLISAITVTPNFKIPSNGLSAGAIAGIVIGSLAFVLLILFVLWKMGYIFRKDQTDKELLELKTGYFSLRQIKAATNNFDLVNKIGEGGFGPVYKGILSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLVYEYMENNSLARAIFGKPEQKLNLDWRTRMKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKHLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVALEIVSGMSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSKYSSEEAMRMLQLALLCTNPSPTLRPPMSSVVSMLEGNTPIQAPIIKRSDSTSGARFKAFELLSHDSQTNVSSTSLQDSRELRGKSMDGPWVDSSISYPSKDYSSSDRLI | 1006 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vivi2g06020 | 1006 | PANTHER | LEUCINE-RICH REPEAT-CONTAINING PROTEIN DDB_G0281931-RELATED | 15 | 963 | - | - | |
Vivi2g06020 | 1006 | FunFam | Probable LRR receptor-like serine/threonine-protein kinase At1g53440 | 34 | 198 | - | - | |
Vivi2g06020 | 1006 | SUPERFAMILY | Protein kinase-like (PK-like) | 643 | 932 | IPR011009 | - | |
Vivi2g06020 | 1006 | Gene3D | - | 407 | 593 | - | - | |
Vivi2g06020 | 1006 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase | 736 | 943 | - | - | |
Vivi2g06020 | 1006 | Gene3D | Transferase(Phosphotransferase) domain 1 | 736 | 945 | - | - | |
Vivi2g06020 | 1006 | SMART | serkin_6 | 660 | 929 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vivi2g06020 | 1006 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase | 404 | 593 | - | - | |
Vivi2g06020 | 1006 | Pfam | Leucine Rich Repeat | 113 | 135 | IPR001611 | GO:0005515 | |
Vivi2g06020 | 1006 | CDD | STKc_IRAK | 666 | 933 | - | - | |
Vivi2g06020 | 1006 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase isoform A | 199 | 266 | - | - | |
Vivi2g06020 | 1006 | ProSiteProfiles | Protein kinase domain profile. | 660 | 942 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vivi2g06020 | 1006 | Gene3D | Phosphorylase Kinase; domain 1 | 627 | 735 | - | - | |
Vivi2g06020 | 1006 | Gene3D | Ribonuclease Inhibitor | 160 | 225 | IPR032675 | - | |
Vivi2g06020 | 1006 | Gene3D | Ribonuclease Inhibitor | 35 | 159 | IPR032675 | - | |
Vivi2g06020 | 1006 | PRINTS | Leucine-rich repeat signature | 303 | 316 | - | - | |
Vivi2g06020 | 1006 | PRINTS | Leucine-rich repeat signature | 114 | 127 | - | - | |
Vivi2g06020 | 1006 | Pfam | Protein tyrosine and serine/threonine kinase | 662 | 930 | IPR001245 | GO:0004672|GO:0006468 | |
Vivi2g06020 | 1006 | Pfam | Leucine rich repeat | 281 | 340 | IPR001611 | GO:0005515 | |
Vivi2g06020 | 1006 | Pfam | Malectin domain | 407 | 588 | IPR021720 | - | |
Vivi2g06020 | 1006 | Gene3D | Ribonuclease Inhibitor | 226 | 406 | IPR032675 | - | |
Vivi2g06020 | 1006 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 782 | 794 | IPR008271 | GO:0004672|GO:0006468 | |
Vivi2g06020 | 1006 | MobiDBLite | consensus disorder prediction | 966 | 1006 | - | - | |
Vivi2g06020 | 1006 | ProSiteProfiles | Leucine-rich repeat profile. | 305 | 327 | IPR001611 | GO:0005515 | |
Vivi2g06020 | 1006 | FunFam | probable LRR receptor-like serine/threonine-protein kinase At1g53430 | 631 | 735 | - | - | |
Vivi2g06020 | 1006 | SUPERFAMILY | L domain-like | 67 | 373 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vivi2g06020 | Vivi-Chr2 | 191722817 | 191732094 | Dispersed/Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vivi2g06020 | 10 | 1000 | Receptor kinase-like Gene Family | AT1G53440 | 63.304 | 0.0 | 1248 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_DLSV | Vivi2g06020 | PK_Tyr_Ser-Thr | 1.6e-49 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vivi2g06020 | - | - | gmx:121173337 | 1497.26 |